Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy
Archives of Gynecology and Obstetrics Sep 18, 2017
Kozaki M, et al. - This study is performed to examine the predictive factors for the impacts of chemotherapy and prognostic factors in these patients. The outcome of this study suggests therapy-free interval (TFI) has predictive value for response to chemotherapy and prognosis of patients with recurrent cervical cancer after definitive CCRT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries